Skip to main content

Animations

MJFF Publications

1601 - 1610 of 6420 Results
Title
Year
  • Year
  • 2024
  • 2017
  • 2020
  • 2017
  • 2021
  • 2021
  • 2024
  • 2018
  • 2019
  • 2019
  • Summary Details
    OPEN
    Title: Developing Allosteric Chaperones for GBA1-Associated Disorders—An Integrated Computational and Experimental Approach
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms26010009
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Normative morphometric data for cerebral cortical areas over the lifetime of the adult human brain
    Journal Name: NeuroImage
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.neuroimage.2017.05.019
    Citation Count: 78
  • Summary Details
    OPEN
    Title: Conopeptide-Functionalized Nanoparticles Selectively Antagonize Extrasynaptic N-Methyl-d-aspartate Receptors and Protect Hippocampal Neurons from Excitotoxicity In Vitro
    Journal Name: ACS Nano
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acsnano.0c00866
    Citation Count: 14
  • Summary Details
    OPEN
    Title: GBA mutations in Parkinson disease: earlier death but similar neuropathological features
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/ene.13395
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Multiple system atrophy-associated oligodendroglial protein p25α stimulates formation of novel α-synuclein strain with enhanced neurodegenerative potential
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-021-02316-0
    Citation Count: 71
  • Summary Details
    OPEN
    Title: miRMaster 2.0: multi-species non-coding RNA sequencing analyses at scale
    Journal Name: Nucleic Acids Research
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/nar/gkab268
    Citation Count: 40
  • Summary Details
    OPEN
    Title: Genetic and clinical study of PARK7 in Japanese Parkinson's disease
    Journal Name: Heliyon
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.heliyon.2024.e35271
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Somatic copy number gains of α-synuclein (SNCA) in Parkinson’s disease and multiple system atrophy brains
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awy157
    Citation Count: 68
  • Summary Details
    OPEN
    Title: Data-Driven Subtyping of Parkinson’s Disease Using Longitudinal Clinical Records: A Cohort Study
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-018-37545-z
    Citation Count: 134
  • Summary Details
    OPEN
    Title: Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.jalz.2019.08.196
    Citation Count: 39
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.